BIOY — GraniteShares YieldBOOST Biotech ETF
Data updated: 2026-09-11
BIOY — GraniteShares YieldBOOST Biotech ETF. Europe Blend / Core Equity · $693.21K AUM · 1.07% expense ratio. Holdings, fees, performance and SEC filings.
BIOY Fund Overview
BIOY — GraniteShares YieldBOOST Biotech ETF is a US ETF managed by GraniteShares ETF Trust, categorised as Europe Blend / Core Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US ETF
- Manager: GraniteShares ETF Trust
- Category: Europe Blend / Core Equity
- Assets under management: $693.21K
- Ticker: BIOY
- SEC CIK: 0001689873
- SEC series ID: S000086455
- Share class ID: C000252014
BIOY Holdings
Top 2 holdings of GraniteShares YieldBOOST Biotech ETF by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Treasury Bill | 57.03% |
| The Options Clearing Corporation | 1.56% |
BIOY Portfolio Allocation
Asset-class allocation of GraniteShares YieldBOOST Biotech ETF by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Fixed Income | 57.0% |
BIOY Performance
Total returns for BIOY (as of 2026-09-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | 1.0% |
BIOY Costs and Fees
BIOY costs about $107 per $10,000 invested per year in fund expenses.
- Net expense ratio: 1.07%
- Gross expense ratio: 1.07%
- Brokerage commissions: 20.94 bps of average net assets (SEC N-CEN)
BIOY Cashflows
Over the 12 months to 2026-06, GraniteShares YieldBOOST Biotech ETF had net inflows of $750.02K, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-06 | $0 |
| 2026-05 | $750.02K |
BIOY Debt Constituents
Largest debt holdings of GraniteShares YieldBOOST Biotech ETF by percentage of net assets, from the latest SEC N-PORT filing.
| Debt holding | % of net assets |
|---|---|
| Treasury Bill | 57.03% |
BIOY Prospectus and SEC Filings
Official GraniteShares YieldBOOST Biotech ETF filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other Europe Blend / Core Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.